These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 20802016

  • 1. Radiation-guided drug delivery to mouse models of lung cancer.
    Hariri G, Yan H, Wang H, Han Z, Hallahan DE.
    Clin Cancer Res; 2010 Oct 15; 16(20):4968-77. PubMed ID: 20802016
    [Abstract] [Full Text] [Related]

  • 2. Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.
    Lim SH, Li CH, Jeong YI, Jang WY, Choi JM, Jung S.
    Int J Nanomedicine; 2019 Oct 15; 14():8861-8874. PubMed ID: 32009784
    [Abstract] [Full Text] [Related]

  • 3. Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked "nanosponge" network for lung cancer chemotherapy.
    Hariri G, Edwards AD, Merrill TB, Greenbaum JM, van der Ende AE, Harth E.
    Mol Pharm; 2014 Jan 06; 11(1):265-75. PubMed ID: 24215299
    [Abstract] [Full Text] [Related]

  • 4. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.
    Zhou Q, Ching AK, Leung WK, Szeto CY, Ho SM, Chan PK, Yuan YF, Lai PB, Yeo W, Wong N.
    Int J Oncol; 2011 Mar 06; 38(3):721-31. PubMed ID: 21240457
    [Abstract] [Full Text] [Related]

  • 5. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery.
    Fu Q, Sun J, Zhang W, Sui X, Yan Z, He Z.
    Recent Pat Anticancer Drug Discov; 2009 Nov 06; 4(3):262-72. PubMed ID: 19538176
    [Abstract] [Full Text] [Related]

  • 6. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model.
    Bressand D, Novell A, Girault A, Raoul W, Fromont-Hankard G, Escoffre JM, Lecomte T, Bouakaz A.
    Mol Pharm; 2019 Sep 03; 16(9):3814-3822. PubMed ID: 31356090
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.
    Lowery A, Onishko H, Hallahan DE, Han Z.
    J Control Release; 2011 Feb 28; 150(1):117-24. PubMed ID: 21075152
    [Abstract] [Full Text] [Related]

  • 10. Enhancing intratumoral biodistribution and antitumor activity of nab-paclitaxel through combination with a vascular disrupting agent, combretastatin A-4-phosphate.
    Gao M, Zhang D, Yao N, Jin Q, Jiang C, Zhang J, Wang F.
    Cancer Chemother Pharmacol; 2019 Dec 28; 84(6):1187-1194. PubMed ID: 31520101
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nab-Paclitaxel Plus S-1 Shows Increased Antitumor Activity in Patient-Derived Pancreatic Cancer Xenograft Mouse Models.
    Li JA, Xu XF, Han X, Fang Y, Shi CY, Jin DY, Lou WH.
    Pancreas; 2016 Mar 28; 45(3):425-33. PubMed ID: 26495780
    [Abstract] [Full Text] [Related]

  • 14. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration.
    Chen N, Brachmann C, Liu X, Pierce DW, Dey J, Kerwin WS, Li Y, Zhou S, Hou S, Carleton M, Klinghoffer RA, Palmisano M, Chopra R.
    Cancer Chemother Pharmacol; 2015 Oct 28; 76(4):699-712. PubMed ID: 26231955
    [Abstract] [Full Text] [Related]

  • 15. Nab-paclitaxel is an active drug in preclinical model of pediatric solid tumors.
    Zhang L, Marrano P, Kumar S, Leadley M, Elias E, Thorner P, Baruchel S.
    Clin Cancer Res; 2013 Nov 01; 19(21):5972-83. PubMed ID: 23989978
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J, Fushida S, Tsukada T, Oyama K, Watanabe T, Shoji M, Okamoto K, Nakanuma S, Sakai S, Makino I, Furukawa H, Hayashi H, Nakamura K, Inokuchi M, Nakagawara H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Fujimura T, Masakazu Y, Hirakawa K, Ohta T.
    Oncol Rep; 2014 Jul 01; 32(1):89-96. PubMed ID: 24859429
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H.
    Biomaterials; 2008 Mar 01; 29(9):1233-41. PubMed ID: 18093646
    [Abstract] [Full Text] [Related]

  • 18. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R, Van Woensel M, Gelbcke M, Mathieu V, Hecq J, Mathivet T, Vermeersch M, Van Antwerpen P, Amighi K, Wauthoz N.
    Mol Pharm; 2018 Mar 05; 15(3):899-910. PubMed ID: 29341619
    [Abstract] [Full Text] [Related]

  • 19. PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.
    Kapoor V, Singh AK, Rogers BE, Thotala D, Hallahan DE.
    J Control Release; 2019 Mar 28; 298():194-201. PubMed ID: 30763622
    [Abstract] [Full Text] [Related]

  • 20. Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.
    Passarella RJ, Spratt DE, van der Ende AE, Phillips JG, Wu H, Sathiyakumar V, Zhou L, Hallahan DE, Harth E, Diaz R.
    Cancer Res; 2010 Jun 01; 70(11):4550-9. PubMed ID: 20484031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.